Correlation Between Chimerix and Keros Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chimerix and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chimerix and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chimerix and Keros Therapeutics, you can compare the effects of market volatilities on Chimerix and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chimerix with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chimerix and Keros Therapeutics.

Diversification Opportunities for Chimerix and Keros Therapeutics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Chimerix and Keros is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Chimerix and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Chimerix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chimerix are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Chimerix i.e., Chimerix and Keros Therapeutics go up and down completely randomly.

Pair Corralation between Chimerix and Keros Therapeutics

Given the investment horizon of 90 days Chimerix is expected to under-perform the Keros Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Chimerix is 1.06 times less risky than Keros Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Keros Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,936  in Keros Therapeutics on August 28, 2024 and sell it today you would earn a total of  1,722  from holding Keros Therapeutics or generate 43.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Chimerix  vs.  Keros Therapeutics

 Performance 
       Timeline  
Chimerix 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chimerix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Keros Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Chimerix and Keros Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chimerix and Keros Therapeutics

The main advantage of trading using opposite Chimerix and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chimerix position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.
The idea behind Chimerix and Keros Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume